Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 28, 2025 | (Q2)Jun 29, 2025 | (Q1)Mar 30, 2025 | (FY)Dec 29, 2024 | (Q4)Dec 29, 2024 | (Q3)Sep 29, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.88%282.97M | -3.77%272.8M | 2.90%284.8M | -0.92%1.13B | 3.45%285.14M | 4.27%285.47M | -1.38%283.5M | -9.11%276.78M | -3.36%1.14B | -5.72%275.64M |
| Operating revenue | -0.88%282.97M | -3.77%272.8M | 2.90%284.8M | -0.92%1.13B | 3.45%285.14M | 4.27%285.47M | -1.38%283.5M | -9.11%276.78M | -3.36%1.14B | -5.72%275.64M |
| Cost of revenue | 1.17%196.38M | 0.61%192.59M | 2.97%196.26M | -4.71%769.27M | -1.59%193.13M | 0.18%194.12M | -4.55%191.43M | -12.03%190.59M | -4.96%807.26M | -7.81%196.25M |
| Gross profit | -5.22%86.58M | -12.88%80.21M | 2.73%88.55M | 8.22%361.63M | 15.90%92.02M | 14.18%91.35M | 5.94%92.07M | -1.89%86.19M | 0.72%334.15M | -0.13%79.39M |
| Operating expense | -6.47%39.37M | 2.99%43.53M | -0.05%42.64M | 9.28%169.05M | 8.65%42.02M | 10.22%42.09M | 12.31%42.27M | 6.16%42.67M | -0.72%154.69M | -0.38%38.68M |
| Selling and administrative expenses | -7.58%34.08M | 2.19%37.64M | -1.22%36.91M | 9.76%147.46M | 10.03%36.38M | 11.02%36.87M | 14.55%36.83M | 4.06%37.37M | 0.13%134.34M | -0.46%33.07M |
| -Selling and marketing expense | -10.93%22.48M | -1.74%23.99M | -1.32%24.32M | 5.83%98.59M | 7.27%24.28M | 11.86%25.24M | 8.24%24.42M | -2.93%24.65M | -2.33%93.16M | -2.46%22.64M |
| -General and administrative expense | -0.33%11.59M | 9.92%13.65M | -1.03%12.59M | 18.64%48.86M | 16.01%12.1M | 9.25%11.63M | 29.38%12.41M | 20.96%12.72M | 6.20%41.19M | 4.18%10.43M |
| Research and development costs | -0.84%5.18M | 6.05%5.76M | 5.32%5.58M | 6.11%21.59M | 0.53%5.64M | 4.84%5.22M | -0.82%5.44M | 23.80%5.3M | 11.51%20.35M | 9.61%5.61M |
| Other operating expenses | --117K | --127K | --153K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | -4.15%47.21M | -26.35%36.68M | 5.46%45.9M | 7.31%192.58M | 22.79%49.99M | 17.79%49.26M | 1.08%49.8M | -8.68%43.53M | 1.99%179.46M | 0.10%40.71M |
| Net non-operating interest income (expenses) | -50.07%2.85M | -54.82%2.68M | -55.30%2.76M | 13.32%26.67M | -21.08%5.16M | 13.45%5.71M | 52.73%5.93M | 69.90%6.17M | 316.90%23.53M | 16.15%6.54M |
| Non-operating interest income | -43.58%3.86M | -47.08%3.75M | -45.12%4.14M | 12.92%27.57M | -15.92%6.11M | 2.03%6.83M | 29.90%7.09M | 50.92%7.53M | 280.70%24.42M | 101.22%7.27M |
| Non-operating interest expense | -10.60%1M | -7.57%1.07M | 1.10%1.38M | 2.26%904K | 30.62%947K | -32.51%1.12M | -26.32%1.16M | 0.15%1.36M | 14.95%884K | 135.87%725K |
| Other net income (expenses) | 84.42%-156K | 161.04%1.06M | -390.32%-1.37M | -190.76%-9.31M | -360.42%-2.61M | 5.30%-1M | -528.22%-1.73M | -131.42%-279K | 57.37%-3.2M | 123.72%1M |
| Gain on sale of security | 84.42%-156K | 161.04%1.06M | -390.32%-1.37M | -401.70%-4.62M | -260.72%-1.61M | 5.30%-1M | -347.85%-1.73M | -131.42%-279K | 141.76%1.53M | 359.84%1M |
| Special income (charges) | ---- | ---- | ---- | 0.97%-4.69M | ---1M | --0 | --0 | ---- | -23.19%-4.73M | --0 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --1M | --1M | ---- | ---- | ---- | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --294K | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | 16.94%-3.69M | ---- | ---- | ---- | ---- | -15.53%-4.44M | ---- |
| Income before tax | -7.52%49.91M | -25.16%40.41M | -4.31%47.29M | 5.08%209.94M | 8.88%52.55M | 17.85%53.97M | 0.83%54M | -5.29%49.42M | 14.77%199.79M | 14.69%48.26M |
| Income tax | -8.62%13.4M | -30.08%10.47M | -5.85%12.85M | 12.77%58.87M | 17.64%15.58M | 22.46%14.66M | 10.66%14.98M | 1.48%13.65M | 13.82%52.2M | 17.83%13.24M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -7.11%36.51M | -23.27%29.94M | -3.72%34.45M | 2.36%151.07M | 5.57%36.97M | 16.22%39.31M | -2.49%39.02M | -7.64%35.78M | 15.10%147.59M | 13.55%35.02M |
| Net income continuous operations | -7.11%36.51M | -23.27%29.94M | -3.72%34.45M | 2.36%151.07M | 5.57%36.97M | 16.22%39.31M | -2.49%39.02M | -7.64%35.78M | 15.10%147.59M | 13.55%35.02M |
| Noncontrolling interests | -83.23%138K | -237.11%-266K | -151.78%-131K | 400.56%1.61M | 102.35%344K | 592.81%823K | 1,663.64%194K | 145.92%253K | -355.08%-537K | 142.82%170K |
| Net income attributable to the company | -5.49%36.38M | -22.20%30.21M | -2.66%34.58M | 0.89%149.46M | 5.10%36.62M | 13.22%38.49M | -2.95%38.83M | -9.58%35.52M | 15.42%148.13M | 11.56%34.85M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -5.49%36.38M | -22.20%30.21M | -2.66%34.58M | 0.89%149.46M | 5.10%36.62M | 13.22%38.49M | -2.95%38.83M | -9.58%35.52M | 15.42%148.13M | 11.56%34.85M |
| Diluted earnings per share | -1.64%0.6 | -19.67%0.49 | 1.82%0.56 | 3.07%2.35 | 7.41%0.58 | 17.31%0.61 | -1.61%0.61 | -8.33%0.55 | 15.74%2.28 | 12.50%0.54 |
| Basic earnings per share | -1.64%0.6 | -19.67%0.49 | 1.82%0.56 | 3.07%2.35 | 7.41%0.58 | 17.31%0.61 | -1.61%0.61 | -8.33%0.55 | 15.74%2.28 | 12.50%0.54 |
| Dividend per share | -2.92%0.0359 | 66.83%0.0365 | 57.36%0.0349 | 29.55%0.116 | 54.06%0.0348 | 67.68%0.037 | -3.25%0.0219 | 0.10%0.0222 | -2.03%0.0895 | 2.31%0.0226 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.